News

The Food and Drug Administration this week released guidance for institutional review boards seeking clarity regarding the key factors and procedures they should consider when reviewing requests by physicians and others for individual patient access to investigational drugs.

Social distancing interventions started earlier in the COVID-19 epidemic appear to delay the epidemic curve while interventions started later appear to flatten it, according to a new study published in the Centers for Disease Control and Prevention’s Emerging Infectious Diseases Journal.

The Centers for Medicare & Medicaid Services recently issued new guidance implementing the Medicaid Optional Uninsured COVID-19 Testing (XXIII) Group, established by the Families First Coronavirus Response Act. 

The Senate approved by unanimous consent the AHA-supported Paycheck Protection Program Flexibility Act of 2020 (H.R. 7010) to allow more leeway for small business loans during the COVID-19 crisis.

June 5 is the fourth annual Hospitals Against Violence Hope (#HAVhope) Friday.

During Community Health Improvement Week, the AHA is sharing stories, resources, tools and leadership blogs that reflect on the importance of community and highlight strong hospital-community partnerships that are helping people live healthier lives.

The Food and Drug Administration recently created an online compendium page of COVID-19 resources for health care professionals.

The Food and Drug Administration authorized the emergency use of two new products designed to respond to the COVID-19 ventilator shortage.

U.S. hospital emergency department visits declined by an estimated 42% between March 29 and April 25 compared to a year ago, while visits for infectious disease screening or exposure were nearly four times higher, according to a report released by the Centers for Disease Control and Prevention.

NATO issued a statement condemning “destabilising and malicious cyber activities directed against those whose work is critical to the response against the pandemic,” including hospitals, health care services and research institutes.

The Center for Medicare and Medicaid Innovation today announced several COVID-19-related modifications to current and future CMMI alternative payment models.

The Department of Health and Human Services said it is providing an additional $250 million to aid health systems’ response to the COVID-19 pandemic.

June 3rd is the deadline for eligible health care providers to submit their revenue information to the Department of Health and Human Services to potentially qualify for an additional payment from the $50 billion general distribution of provider relief emergency funds.

The Department of Health and Human Services June 1 announced that the next deadline for submitting data to inform the agency’s distribution of its supply of remdesivir is June 8 at 8 p.m. ET.

Leaders of the House Energy and Commerce and Senate Finance committees asked Health and Human Services Secretary Alex Azar to clarify by June 10 the agency’s plan and timeline for disbursing COVID-19 emergency relief funds to Medicaid-dependent providers.

Maryland primary care practices and federally qualified health centers can apply through July 14 to participate in the state’s Total Cost of Care Model.

The Centers for Disease Control and Prevention

The Food and Drug Administration updated guidance to spur wider availability of alcohol-based hand sanitizers during the COVID-19 pandemic.

The Health Resources and Services Administration awarded $20.3 million to increase the number of fellows at accredited addiction medicine and addiction psychiatry fellowship programs.

The Centers for Medicare & Medicaid Services implemented several new infection control actions to combat COVID-19 in nursing homes.